Clinical Trial Update: A Study to Evaluate the Effects of Veliparib on Heart Rhythms in Patients With Solid Tumors [Phase 1]

View source ↗

Summary

This Phase 1 study evaluated the effects of Veliparib on heart rhythms in patients with solid tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colon Cancer
• Gastric Cancer
• Lung Cancer
• Ovarian Cancer

Drugs mentioned

• Veliparib (veliparib)

Snippet

Sponsor: AbbVie | Conditions: Breast Cancer, Ovarian Cancer | Phase 1 | Status: COMPLETED